INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Import this data to Google Sheets with:

=jivedata("IART","financials")

Full statements spill as a table. For one cell: =jivedata("IART","Revenue") or =jivedata("IART","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

INTEGRA LIFESCIENCES HOLDINGS CORP

IART • CIK 0000917520

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$1,541,573	$1,610,527	$1,635,245	$1,647,666
Operating Income (Loss)	$111,526	$28,411	$-493,370	$65,556
Investment Income, Interest	$17,202	$20,040	$18,474	$17,716
InterestExpenseNonoperating	—	$70,632	$86,255	$91,857
Other Nonoperating Income (Expense)	$3,718	$3,944	$-2,351	$8,404
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$81,069	$-18,237	$-563,502	$-181
Income Tax Expense (Benefit)	$13,328	$-11,293	$-47,028	$7,061
Net Income (Loss) Attributable to Parent	$67,741	$-6,944	$-516,474	$-7,242
Cost of Goods and Services Sold	$656,838	$728,466	$803,625	$783,084
Research and Development Expense (Excluding Acquired in Process Cost)	$104,192	$115,377	$98,971	$95,000
Selling, General and Administrative Expense	$656,641	$716,983	$699,700	$688,984
Amortization of Intangible Assets	$12,376	$21,290	$14,954	$15,042
Goodwill, Impairment Loss	—	—	$511,365	$0
Costs and Expenses	$1,430,047	$1,582,116	$2,128,615	$1,582,110
Weighted Average Number of Shares Outstanding, Basic	80,089,000	77,010,000	76,672,000	77,215,000
Weighted Average Number of Shares Outstanding, Diluted	80,337,000	77,010,000	76,672,000	77,215,000
Stockholders' Equity Attributable to Parent	$1,587,884	$1,545,280	$1,043,463	$561,730
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	$-22,071	$62,638	$-56,054	$-56,054

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$276,402	$246,375	$235,048	$214,415
Short-term Investments	$32,694	$27,192	$28,693	$59,669
Property, Plant and Equipment, Net	$340,199	$405,723	$444,335	$446,202
Accounts Receivable, after Allowance for Credit Loss, Current	$259,327	$272,370	$278,849	$267,188
Operating Lease, Right-of-Use Asset	$156,184	$144,042	$140,568	$137,085
Inventory, Net	$389,608	$429,090	$492,735	$492,005
Intangible Assets, Net (Excluding Goodwill)	$1,067,833	$1,207,588	$1,134,663	$1,075,542
Prepaid Expense, Current	$67,362	$77,001	$96,089	$104,344
Goodwill	$1,055,462	$1,096,952	$615,157	$611,145
Other Assets, Current	$32,643	$29,653	$28,130	$53,861
Deferred Income Tax Assets, Net	$46,080	$34,923	$69,854	$70,443
Assets, Current	$1,058,036	$1,081,681	$1,159,544	$1,191,482
Other Assets, Noncurrent	$58,194	$66,515	$37,880	$31,591
Assets	$3,781,988	$4,037,424	$3,602,001	$3,563,490
Secured Long-term Debt, Noncurrent	$825,563	$1,087,917	$1,729,556	$1,736,105
Operating Lease, Liability, Noncurrent	$166,849	$166,930	$163,059	$162,660
Deferred Income Tax Liabilities, Net	$35,317	$60,833	$5,664	$3,470
Other Liabilities, Noncurrent	$199,940	$146,238	$204,278	$194,397
Liabilities	$2,194,104	$2,492,144	$2,558,538	$2,520,113
Secured Debt, Current	$14,531	$33,906	$38,750	$43,594
Operating Lease, Liability, Current	$15,284	$14,540	$14,019	$13,920
Convertible Debt, Current	—	$573,170	$0	$0
Accounts Payable, Trade, Current	$92,326	$82,502	$95,726	$82,637
Contract with Customer, Liability, Current	$8,540	$10,483	$11,463	$11,699
Taxes Payable, Current	—	—	$3,651	$3,236
Employee-related Liabilities, Current	$75,455	$85,617	$74,079	$68,177
Accrued Liabilities, Current	$100,844	$121,908	$130,493	$107,618
Liabilities, Current	$306,980	$922,126	$455,981	$330,881
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$909	$916	$923	$921
Additional Paid in Capital, Common Stock	$1,302,484	$1,323,431	$1,338,386	$1,346,265
Treasury Stock, Common, Value	$647,262	$691,411	$689,210	$686,918
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-15,106	$-27,571	$-30,077	$-40,197
Retained Earnings (Accumulated Deficit)	$946,859	$939,915	$423,441	$423,306
Stockholders' Equity Attributable to Parent	$1,587,884	$1,545,280	$1,043,463	$1,043,377
Accounts Receivable, Allowance for Credit Loss, Current	$4,879	$6,917	$7,230	$7,326
Preferred Stock, Shares Authorized	15,000,000	15,000,000	15,000,000	15,000,000
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	240,000,000	240,000,000	240,000,000	240,000,000
Common Stock, Shares, Issued	90,920,000	91,610,000	92,286,000	92,130,000
Treasury Stock, Common, Shares	12,751,000	14,445,000	14,399,000	14,351,000
Operating Lease, Liability	$182,133	$181,470	$177,078	$176,580

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$67,741	$-6,944	$-516,474	$-7,242
Net Cash Provided by (Used in) Operating Activities	$139,955	$129,382	$50,384	$85,327
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$3,889	$-6,464	$18,017	$-1,776
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-180,259	$-30,027	$-11,327	$-3,499
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$276,402	$246,375	$235,048	$232,753
Other Depreciation and Amortization	$123,512	$140,893	$151,832	$153,517
Payments to Acquire Property, Plant, and Equipment	$66,865	$104,418	$81,436	$59,525
Impairment of Intangible Assets, Finite-lived	$0	$12,209	$511,365	$0
Payments to Acquire Intangible Assets	—	$9,953	$14,202	$14,202
Deferred Income Tax Expense (Benefit)	$-11,885	$-20,731	$-66,264	$-22,608
Payments to Acquire Investments	$32,694	$48,997	$8,502	$30,976
Share-based Payment Arrangement, Noncash Expense	$20,143	$24,377	$18,583	$22,427
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	—	$54,500	$7,000	$7,000
Payments for (Proceeds from) Derivative Instrument, Investing Activities	$-5,381	$4,129	$10,923	$10,923
Net Cash Provided by (Used in) Investing Activities	$-94,178	$-390,808	$-108,063	$-108,626
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$12,888	$-5,791	$-21,329	$-21,900
Proceeds from Issuance of Secured Debt	$165,100	$486,500	$720,700	$729,300
Repayments of Secured Debt	$110,600	$187,131	$94,906	$124,250
Repayments of Convertible Debt	—	—	$574,983	$574,983
Payments of Debt Issuance Costs	$7,879	$0	$4,064	$484
Payments for Repurchase of Common Stock	$275,000	$52,471	$221	$0
Payment for Contingent Consideration Liability, Financing Activities	—	$11,923	$16,451	$6,842
Proceeds from Stock Options Exercised	$4,317	$6,398	$957	$957
Payment, Tax Withholding, Share-based Payment Arrangement	$5,863	$3,510	$2,697	$1,925
Net Cash Provided by (Used in) Financing Activities	$-229,925	$237,863	$28,335	$21,576
Increase (Decrease) in Accounts Receivable	$-4,593	$-7,398	$485	$-16,659
Increase (Decrease) in Inventories	$59,773	$28,149	$46,760	$30,541
Increase (Decrease) in Prepaid Expense and Other Assets	$-2,652	$8,187	$2,802	$10,903
Increase (Decrease) in Other Operating Assets	$8,535	$2,842	$-3,343	$-1,398
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-20,229	$-2,674	$26,724	$-5,582
Increase (Decrease) in Contract with Customer, Liability	$128	$3,540	$3,400	$-336
Increase (Decrease) in Other Noncurrent Liabilities	$-410	$-93	$-17,156	$-18,495

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IART","financials")

Full statements spill as a table. For one cell: =jivedata("IART","Revenue") or =jivedata("IART","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.